vs

Side-by-side financial comparison of MILESTONE SCIENTIFIC INC. (MLSS) and Origin Materials, Inc. (ORGN). Click either name above to swap in a different company.

Origin Materials, Inc. is the larger business by last-quarter revenue ($3.0M vs $2.1M, roughly 1.5× MILESTONE SCIENTIFIC INC.). MILESTONE SCIENTIFIC INC. runs the higher net margin — -53.0% vs -6423.8%, a 6370.8% gap on every dollar of revenue. On growth, MILESTONE SCIENTIFIC INC. posted the faster year-over-year revenue change (2.2% vs -67.2%). Over the past eight quarters, MILESTONE SCIENTIFIC INC.'s revenue compounded faster (-4.3% CAGR vs -33.5%).

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Origin Systems, Inc. was an American video game developer based in Austin, Texas. It was founded on March 3, 1983, by Richard Garriott and his brother Robert. Origin is best known for their groundbreaking work in multiple genres of video games, such as the Ultima and Wing Commander series. The company was purchased by Electronic Arts in 1992.

MLSS vs ORGN — Head-to-Head

Bigger by revenue
ORGN
ORGN
1.5× larger
ORGN
$3.0M
$2.1M
MLSS
Growing faster (revenue YoY)
MLSS
MLSS
+69.4% gap
MLSS
2.2%
-67.2%
ORGN
Higher net margin
MLSS
MLSS
6370.8% more per $
MLSS
-53.0%
-6423.8%
ORGN
Faster 2-yr revenue CAGR
MLSS
MLSS
Annualised
MLSS
-4.3%
-33.5%
ORGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MLSS
MLSS
ORGN
ORGN
Revenue
$2.1M
$3.0M
Net Profit
$-1.1M
$-194.1M
Gross Margin
73.0%
Operating Margin
-52.5%
-6438.5%
Net Margin
-53.0%
-6423.8%
Revenue YoY
2.2%
-67.2%
Net Profit YoY
46.4%
-1335.6%
EPS (diluted)
$-50.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLSS
MLSS
ORGN
ORGN
Q4 25
$2.1M
$3.0M
Q3 25
$2.4M
$4.7M
Q2 25
$2.3M
$5.8M
Q1 25
$2.2M
$5.4M
Q4 24
$2.0M
$9.2M
Q3 24
$2.5M
$8.2M
Q2 24
$1.9M
$7.0M
Q1 24
$2.2M
$6.8M
Net Profit
MLSS
MLSS
ORGN
ORGN
Q4 25
$-1.1M
$-194.1M
Q3 25
$-1.2M
$-16.4M
Q2 25
$-1.5M
$-12.7M
Q1 25
$-2.0M
$-26.4M
Q4 24
$-2.0M
$-13.5M
Q3 24
$-1.5M
$-36.8M
Q2 24
$223.6K
$-19.5M
Q1 24
$-1.4M
$-13.9M
Gross Margin
MLSS
MLSS
ORGN
ORGN
Q4 25
73.0%
Q3 25
69.5%
Q2 25
69.6%
Q1 25
73.8%
Q4 24
75.0%
Q3 24
73.0%
Q2 24
76.1%
Q1 24
74.5%
Operating Margin
MLSS
MLSS
ORGN
ORGN
Q4 25
-52.5%
-6438.5%
Q3 25
-48.1%
-363.6%
Q2 25
-63.9%
-257.5%
Q1 25
-89.5%
-600.8%
Q4 24
-101.4%
-175.7%
Q3 24
-58.4%
-395.1%
Q2 24
-96.0%
-259.6%
Q1 24
-65.1%
-263.7%
Net Margin
MLSS
MLSS
ORGN
ORGN
Q4 25
-53.0%
-6423.8%
Q3 25
-48.9%
-351.8%
Q2 25
-63.8%
-219.3%
Q1 25
-89.3%
-486.9%
Q4 24
-101.1%
-146.6%
Q3 24
-58.1%
-448.2%
Q2 24
12.1%
-277.3%
Q1 24
-64.1%
-203.9%
EPS (diluted)
MLSS
MLSS
ORGN
ORGN
Q4 25
$-50.17
Q3 25
$-0.01
$-0.11
Q2 25
$-0.09
Q1 25
$-0.18
Q4 24
$-17.04
Q3 24
$-0.02
$-0.26
Q2 24
$-0.14
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLSS
MLSS
ORGN
ORGN
Cash + ST InvestmentsLiquidity on hand
$1.1M
$32.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.8M
$104.2M
Total Assets
$7.8M
$157.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLSS
MLSS
ORGN
ORGN
Q4 25
$1.1M
$32.9M
Q3 25
$1.3M
$34.1M
Q2 25
$1.3M
$35.3M
Q1 25
$2.2M
$43.8M
Q4 24
$3.3M
$56.3M
Q3 24
$4.8M
$56.4M
Q2 24
$5.8M
$55.7M
Q1 24
$5.0M
$75.8M
Stockholders' Equity
MLSS
MLSS
ORGN
ORGN
Q4 25
$2.8M
$104.2M
Q3 25
$2.5M
$295.0M
Q2 25
$3.3M
$311.1M
Q1 25
$4.5M
$314.6M
Q4 24
$5.8M
$338.4M
Q3 24
$7.2M
$358.9M
Q2 24
$8.0M
$390.6M
Q1 24
$7.5M
$408.2M
Total Assets
MLSS
MLSS
ORGN
ORGN
Q4 25
$7.8M
$157.7M
Q3 25
$8.5M
$327.3M
Q2 25
$8.1M
$348.4M
Q1 25
$9.1M
$349.0M
Q4 24
$9.8M
$378.0M
Q3 24
$11.2M
$399.6M
Q2 24
$12.0M
$431.0M
Q1 24
$11.4M
$448.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLSS
MLSS
ORGN
ORGN
Operating Cash FlowLast quarter
$-226.1K
$-8.9M
Free Cash FlowOCF − Capex
$-18.0M
FCF MarginFCF / Revenue
-596.6%
Capex IntensityCapex / Revenue
301.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-63.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLSS
MLSS
ORGN
ORGN
Q4 25
$-226.1K
$-8.9M
Q3 25
$81.8K
$-8.1M
Q2 25
$-1.8M
$-7.3M
Q1 25
$-1.0M
$-8.4M
Q4 24
$-1.5M
$-5.7M
Q3 24
$-973.9K
$-13.4M
Q2 24
$783.7K
$-15.0M
Q1 24
$-1.2M
$-16.7M
Free Cash Flow
MLSS
MLSS
ORGN
ORGN
Q4 25
$-18.0M
Q3 25
$-13.5M
Q2 25
$-16.0M
Q1 25
$-15.4M
Q4 24
$-9.5M
Q3 24
$-16.0M
Q2 24
$-15.6M
Q1 24
$-18.7M
FCF Margin
MLSS
MLSS
ORGN
ORGN
Q4 25
-596.6%
Q3 25
-290.5%
Q2 25
-275.4%
Q1 25
-284.2%
Q4 24
-103.5%
Q3 24
-194.7%
Q2 24
-221.8%
Q1 24
-273.6%
Capex Intensity
MLSS
MLSS
ORGN
ORGN
Q4 25
301.4%
Q3 25
115.7%
Q2 25
149.9%
Q1 25
128.8%
Q4 24
41.6%
Q3 24
31.0%
Q2 24
9.0%
Q1 24
28.4%
Cash Conversion
MLSS
MLSS
ORGN
ORGN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.50×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons